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Background:  Following the Fontan operation, single ventricle patients are at substantial risk for the development of impaired functional status. 
However, few early markers of suboptimal outcomes have been identified. We sought to determine if low peripheral vascular function might be a 
marker of altered exercise performance.
Methods:  Asymptomatic Fontan patients 8-25 years of age were recruited along with age- and sex-matched healthy controls. Endothelial pulse 
amplitude was measured at baseline and during reactive hyperemia using a non-invasive fingertip peripheral arterial tonometry (PAT) device. Raw 
data were transformed into the PAT ratio, an established marker of vascular function. Cardiopulmonary exercise testing was performed using the 
Bruce protocol.
Results:  Fifty-one Fontan patients (median 15 years [IQR 10.9-17.8]) and 22 controls (15 years [12.5-16.9]) completed testing. Demographics 
and baseline characteristics were similar between groups. In the Fontan cohort, 94% of patients were NYHA functional class I and 88% had a BNP 
level <50 pg/mL. Baseline pulse amplitude, a measure that reflects resting arterial tone, was higher in Fontan patients than controls (274 [196-
413] vs. 186 [114-279], p=0.03). PAT ratio, a measure of reactive hyperemia, was lower in Fontan patients (0.17 [-0.04-0.44] vs. 0.50 [0.27-0.74], 
p=0.002). Key parameters of exercise performance, including peak oxygen consumption (VO2, 28.8 [25.6-33.2] vs. 45.5 [41.7-49.9] ml/kg/min, 
p<0.0001) and peak work (192 [150-246] vs. 330 [209-402] Watts, p<0.0001), were lower in Fontan patients compared with controls. PAT ratio 
correlated with peak VO2 (r=0.28, p=0.02) and peak work (r=0.26, p=0.03).
Conclusions:  In asymptomatic Fontan patients, there is evidence of reduced basal peripheral arterial tone and vasodilator response, suggesting 
dysfunction of the endothelium-derived nitric oxide pathway. Vasodilator function appears to correlate modestly with exercise performance. 
Longitudinal study and assessment in a low-performing cohort are necessary to further evaluate the predictive value of endothelial pulse amplitude 
testing as an early marker of reduced exercise capacity in Fontan patients.
